av/genmab-a-s--big.svg

COM:GENMAB

Genmab A/S

  • Stock

DKK

Last Close

1,483.50

25/11 09:37

Market Cap

116.34B

Beta: -

Volume Today

13.98K

Avg: -

  • name

    Genmab A/S
  • homepage url

    www.genmab.com
  • country

    DKDenmark
  • linkedin url

    genmab
  • crunchbase url

    genmab
  • employee count

    2,286
  • sector

    Healthcare
  • industry

    Biotechnology
  • revenue

    2.33B

Description

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphocytic leukemia (CLL) and multiple ...Show More

peer of

invested in

competitor of